Abbott Laboratories (ABT)
NYSE • Healthcare
August 18, 2026 at 20:00 UTC
About Abbott Laboratories
Abbott Laboratories (NYSE: ABT) is a healthcare company centered on medical devices, diagnostics, nutrition, and branded generic medications sold through worldwide distribution, with operations that reach global markets. Across these businesses, Abbott generated $44.3 billion of revenue in FY2025, spanning products used in testing, chronic disease management, and everyday nutritional care.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Abbott Laboratories's Technical Indicators Summary
ABT exhibits a strong buy profile with a robust ADX indicating a firm trend and multiple momentum measures, including MACD and CCI, signaling bullishness while the stock trades around 112.68 above most short- and medium-term averages. RSI and Stochastic are elevated, suggesting overbought conditions, however the broader moving-average structure through the 200-day remains constructive and OBV supports accumulation despite a negative cumulative level. Volatility is contained by ATR, and the pivot sits below price as support. Technical takeaway: Strong Buy — trend and momentum are dominant despite near-term overbought readings.
| Indicator | Value |
|---|---|
RSI (14) | 73.00 |
Stochastic %K (14, 3, 3) | 85.50 |
CCI (20) | 142.73 |
WPR (14) | -8.85 |
Momentum (10) | 7.22 |
MFI | 61.33 |
MACD Level (12, 26) | 3.82 |
Bollinger Bands | $100.46 - $113.97 |
ATR (14) | $2.69 (2.38%) |
ADX (14) | 33.52 |
OBV | -210,995,205 |
Classic Pivot Point | $110.38 |
Fibonacci Pivot Point | $110.38 |
Simple Moving Averages | $95.50 - $109.63(5 indicators) |
Exponential Moving Averages | $100.69 - $109.75(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
ABT posted a modest gain in the last trading session, rising 2.09% to close at 112.68. ABT raises its earnings outlook after the latest update.
Trading Volume
Below 10d avg (7.7M)
5.3M
vs S&P 500 Today
Outperforming Market
+2.78%
52-Week Position
Mid-range
55.3%
Updated: August 19, 2026 at 12:12 UTC
Quote Summary
ABT Headlines
Abbott hit with $53 million infant formula verdict
April 10, 2026
Citi Resets Life Sciences And MedTech Views
March 11, 2026
Analysts Shift on Key Blue-Chip and Growth Names
February 8, 2026
Lam Research, Broadcom, Oracle Lead Q3 Growth Amid AI Demand
November 12, 2025